Based on current research, stem cell transplantation is primarily recommended for aggressive cases of MS that haven't responded well to standard medications. While the treatment shows promising results, it comes with significant risks including potential mortality (though low at 2.8%).
The procedure involves chemotherapy Show Full Answer
Based on current research, stem cell transplantation is primarily recommended for aggressive cases of MS that haven't responded well to standard medications. While the treatment shows promising results, it comes with significant risks including potential mortality (though low at 2.8%).
The procedure involves chemotherapy to destroy the existing immune system before rebuilding it with stored stem cells - this is a major medical intervention that shouldn't be undertaken lightly. For non-aggressive RRMS that's only slightly symptomatic, the risks may outweigh the potential benefits. The treatment is typically reserved for people who:
• Have had multiple flare-ups in the past year
• Have tried multiple standard medications without success
• Are experiencing worsening disability despite current treatments
It's important to discuss with your healthcare team whether your current symptoms and disease progression warrant such an intensive treatment approach.
August 12, 2025
Join
Your Privacy Choices
